HC Wainwright Brokers Lower Earnings Estimates for NeuroPaceMarket Beat·1 day ago, 06:13 AMNPCE+0.07%BLK+1.47%
Niche Equities Diverge as Maritime and Deep Tech Players Post Massive Revenue GainsGlobal Report·Aug 18 at 05:12 AMLPG+2.98%INTS-0.41%
NeuroPace (NASDAQ:NPCE) Shares Gap Down - Here's WhyMarket Beat·Aug 12 at 12:00 PMNPCE+0.07%BLK+1.47%
NPCE: Q2 2026 RNS revenue grew 21% year-over-year, with robust outlook and expanding market reachQuartr·Aug 11 at 05:43 PMNPCE+0.07%
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga_article·Jul 29 at 07:05 AMNEO+2.72%AMIX0.00%
NeuroPace's Panel Track Supplement Not Approvable in Current Form, FDA SaysMorningStar·Jul 28 at 05:42 PMNPCE+0.07%
NeuroPace says FDA deems epilepsy label expansion filing not approvable in current formPUBT·Jul 28 at 03:33 PMNPCE+0.07%
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga_article·Jul 28 at 04:06 PMVTAK-0.52%NPCE+0.07%
